305 related articles for article (PubMed ID: 30599112)
1. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?
Aruleba RT; Adekiya TA; Oyinloye BE; Masamba P; Mbatha LS; Pretorius A; Kappo AP
Infect Disord Drug Targets; 2019; 19(4):337-349. PubMed ID: 30599112
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
[TBL] [Abstract][Full Text] [Related]
3. Schistosomiasis: Drugs used and treatment strategies.
Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
[TBL] [Abstract][Full Text] [Related]
4. The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment.
Koukounari A; Donnelly CA; Sacko M; Keita AD; Landouré A; Dembelé R; Bosqué-Oliva E; Gabrielli AF; Gouvras A; Traoré M; Fenwick A; Webster JP
BMC Infect Dis; 2010 Jul; 10():227. PubMed ID: 20670408
[TBL] [Abstract][Full Text] [Related]
5. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
[TBL] [Abstract][Full Text] [Related]
6. The promise of antimicrobial peptides for treatment of human schistosomiasis.
Oyinloye B; Adenowo F; Gxaba N; Kappo A
Curr Drug Targets; 2014; 15(9):852-9. PubMed ID: 25101908
[TBL] [Abstract][Full Text] [Related]
7. The Journey to Discovering a Flatworm Target of Praziquantel: A Long TRP.
Park SK; Marchant JS
Trends Parasitol; 2020 Feb; 36(2):182-194. PubMed ID: 31787521
[TBL] [Abstract][Full Text] [Related]
8. Human schistosomiasis.
Gryseels B; Polman K; Clerinx J; Kestens L
Lancet; 2006 Sep; 368(9541):1106-18. PubMed ID: 16997665
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics reveal alterations in arachidonic acid metabolism in Schistosoma mekongi after exposure to praziquantel.
Chienwichai P; Tipthara P; Tarning J; Limpanont Y; Chusongsang P; Chusongsang Y; Adisakwattana P; Reamtong O
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009706. PubMed ID: 34473691
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy.
Fukushige M; Chase-Topping M; Woolhouse MEJ; Mutapi F
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009189. PubMed ID: 33730095
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapeutic approaches to schistosomes: current knowledge and outlook.
Harder A
Parasitol Res; 2002 May; 88(5):395-7. PubMed ID: 12049454
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs.
Levecke B; Vlaminck J; Andriamaro L; Ame S; Belizario V; Degarege A; Engels D; Erko B; Garba AD; Kaatano GM; Mekonnen Z; Montresor A; Olliaro P; Pieri OS; Sacko M; Sam-Wobo SO; Tchuem Tchuenté LA; Webster JP; Vercruysse J
Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():183-187. PubMed ID: 33125936
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
[TBL] [Abstract][Full Text] [Related]
14. In vivo efficiency of praziquantel treatment of single-sex Schistosoma japonicum aged three months old in mice.
Wang N; Peng HQ; Gao CZ; Cheng YH; Sun MT; Qu GL; Webster JP; Lu DB
Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():129-134. PubMed ID: 36403362
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneities in anti-schistosome humoral responses following chemotherapy.
Mutapi F
Trends Parasitol; 2001 Nov; 17(11):518-24. PubMed ID: 11872396
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
17. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility or resistance of praziquantel in human schistosomiasis: a review.
Wang W; Wang L; Liang YS
Parasitol Res; 2012 Nov; 111(5):1871-7. PubMed ID: 23052781
[TBL] [Abstract][Full Text] [Related]
19. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis.
Doenhoff MJ; Cioli D; Utzinger J
Curr Opin Infect Dis; 2008 Dec; 21(6):659-67. PubMed ID: 18978535
[TBL] [Abstract][Full Text] [Related]
20. Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum.
Bustinduy AL; Kolamunnage-Dona R; Mirochnick MH; Capparelli EV; Tallo V; Acosta LP; Olveda RM; Friedman JF; Hope WW
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
